BLIS Technologies (NZSE:BLT) Days Payable : 147.26 (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is BLIS Technologies Days Payable?

BLIS Technologies's average Accounts Payable for the six months ended in Mar. 2024 was NZ$1.04 Mil. BLIS Technologies's Cost of Goods Sold for the six months ended in Mar. 2024 was NZ$1.29 Mil. Hence, BLIS Technologies's Days Payable for the six months ended in Mar. 2024 was 147.26.

The historical rank and industry rank for BLIS Technologies's Days Payable or its related term are showing as below:

NZSE:BLT' s Days Payable Range Over the Past 10 Years
Min: 87.33 Med: 159.3 Max: 239.96
Current: 174.77

During the past 13 years, BLIS Technologies's highest Days Payable was 239.96. The lowest was 87.33. And the median was 159.30.

NZSE:BLT's Days Payable is ranked better than
56.98% of 723 companies
in the Biotechnology industry
Industry Median: 148.78 vs NZSE:BLT: 174.77

BLIS Technologies's Days Payable declined from Mar. 2023 (163.71) to Mar. 2024 (147.26). It may suggest that BLIS Technologies accelerated paying its suppliers.

BLIS Technologies Days Payable Historical Data

The historical data trend for BLIS Technologies's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BLIS Technologies Days Payable Chart

BLIS Technologies Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Days Payable

Get a 7-Day Free Trial

155.24

239.96

217.96

184.17

159.30

BLIS Technologies Semi-Annual Data
	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Days Payable	Get a 7-Day Free Trial															172.97	247.71	163.71	229.59	147.26

Competitive Comparison of BLIS Technologies's Days Payable

For the Biotechnology subindustry, BLIS Technologies's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BLIS Technologies's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BLIS Technologies's Days Payable distribution charts can be found below:

* The bar in red indicates where BLIS Technologies's Days Payable falls into.

BLIS Technologies Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

BLIS Technologies's Days Payable for the fiscal year that ended in Mar. 2024 is calculated as

	Days Payable (A: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Mar. 2023 )	+	Accounts Payable (A: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (A: Mar. 2024 )	*	Days in Period
=	( (1.155	+	0.809)	/	2 )	/	2.25	*	365
=	0.982					/	2.25	*	365
=	159.30

BLIS Technologies's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (1.268	+	0.809)	/	2 )	/	1.287	*	365 / 2
=	1.0385					/	1.287	*	365 / 2
=	147.26

BLIS Technologies Days Payable Related Terms

Thank you for viewing the detailed overview of BLIS Technologies's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

BLIS Technologies (NZSE:BLT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BLIS Technologies Ltd (NZSE:BLT) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

442 Moray Place, Ground Floor, Dunedin, OTA, NZL, 9016

Website

https://www.blis.co.nz

BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets two strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18 both of which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from EMEA (Europe, the Middle East, and Africa).